Posts Tagged ‘FecalSwab®’

Evaluation of the FecalSwab™ for Stool Specimen Storage and Molecular Detection of Enteropathogens on the BD MAX™ System

ABSTRACT The FecalSwab™ system (Copan Italia, Brescia, Italy) is a convenient alternative to bulk stool for the diagnosis of enteric pathogens. Although U.S. Food and Drug Administration (FDA) approved for transport and culture of enteric bacterial pathogens, the FecalSwab™ has not been well assessed for its suitability with molecular platforms. In this study, we evaluated…

Read More

Gut Microbiota Composition Alterations are Associated with the Onset of Diabetes in Kidney Transplant Recipients

BackgroundThe gut dysbiosis associated with diabetes acquired before or after kidney transplantation (KT) has not been explored. MethodsPatients transplanted at our institution provided fecal samples before, and 3–9 months after KT. Fecal bacterial DNA was extracted and 9 bacteria or bacterial groups were quantified by qPCR. Results50 patients (19 controls without diabetes, 15 who developed…

Read More

High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands

AbstractIntroductionThe aim of this study was to determine the rate of asymptomatic carriage and spread of multidrug-resistant micro-organisms (MDRO) and to identify risk factors for extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) carriage in 12 long term care facilities (LTCFs) in Amsterdam, the Netherlands. Materials and methodsFrom November 2014 to august 2015, feces and nasal swabs from…

Read More